224 related articles for article (PubMed ID: 22724006)
21. BORIS/CTCFL epigenetically reprograms clustered CTCF binding sites into alternative transcriptional start sites.
Pugacheva EM; Bhatt DN; Rivero-Hinojosa S; Tajmul M; Fedida L; Price E; Ji Y; Loukinov D; Strunnikov AV; Ren B; Lobanenkov VV
Genome Biol; 2024 Jan; 25(1):40. PubMed ID: 38297316
[TBL] [Abstract][Full Text] [Related]
22. CTCF cis-regulates trinucleotide repeat instability in an epigenetic manner: a novel basis for mutational hot spot determination.
Libby RT; Hagerman KA; Pineda VV; Lau R; Cho DH; Baccam SL; Axford MM; Cleary JD; Moore JM; Sopher BL; Tapscott SJ; Filippova GN; Pearson CE; La Spada AR
PLoS Genet; 2008 Nov; 4(11):e1000257. PubMed ID: 19008940
[TBL] [Abstract][Full Text] [Related]
23. Integrating role of T antigen, Rb2/p130, CTCF and BORIS in mediating non-canonical endoplasmic reticulum-dependent death pathways triggered by chronic ER stress in mouse medulloblastoma.
Macaluso M; Caracciolo V; Rizzo V; Sun A; Montanari M; Russo G; Bellipanni G; Khalili K; Giordano A
Cell Cycle; 2012 May; 11(9):1841-50. PubMed ID: 22544282
[TBL] [Abstract][Full Text] [Related]
24. Dynamic association of the mammalian insulator protein CTCF with centrosomes and the midbody.
Zhang R; Burke LJ; Rasko JE; Lobanenkov V; Renkawitz R
Exp Cell Res; 2004 Mar; 294(1):86-93. PubMed ID: 14980504
[TBL] [Abstract][Full Text] [Related]
25. CTCFL/BORIS is a methylation-independent DNA-binding protein that preferentially binds to the paternal H19 differentially methylated region.
Nguyen P; Cui H; Bisht KS; Sun L; Patel K; Lee RS; Kugoh H; Oshimura M; Feinberg AP; Gius D
Cancer Res; 2008 Jul; 68(14):5546-51. PubMed ID: 18632606
[TBL] [Abstract][Full Text] [Related]
26. BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
Hines WC; Bazarov AV; Mukhopadhyay R; Yaswen P
PLoS One; 2010 Mar; 5(3):e9738. PubMed ID: 20305816
[TBL] [Abstract][Full Text] [Related]
27. A Common Polymorphism within the IGF2 Imprinting Control Region Is Associated with Parent of Origin Specific Effects in Infantile Hemangiomas.
Schultz B; Yao X; Deng Y; Waner M; Spock C; Tom L; Persing J; Narayan D
PLoS One; 2015; 10(10):e0113168. PubMed ID: 26496499
[TBL] [Abstract][Full Text] [Related]
28. BORIS and CTCF are overexpressed in squamous intraepithelial lesions and cervical cancer.
Velázquez-Hernández N; Reyes-Romero MA; Barragán-Hernández M; Guerrero-Romero F; Rodríguez-Moran M; Aguilar-Durán M; Lazalde Medina B
Genet Mol Res; 2015 Jun; 14(2):6094-100. PubMed ID: 26125810
[TBL] [Abstract][Full Text] [Related]
29. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions.
Kang H; Lieberman PM
J Virol; 2009 Jun; 83(12):6199-210. PubMed ID: 19369356
[TBL] [Abstract][Full Text] [Related]
30. Coordinated cancer germline antigen promoter and global DNA hypomethylation in ovarian cancer: association with the BORIS/CTCF expression ratio and advanced stage.
Woloszynska-Read A; Zhang W; Yu J; Link PA; Mhawech-Fauceglia P; Collamat G; Akers SN; Ostler KR; Godley LA; Odunsi K; Karpf AR
Clin Cancer Res; 2011 Apr; 17(8):2170-80. PubMed ID: 21296871
[TBL] [Abstract][Full Text] [Related]
31. BORIS promotes chromatin regulatory interactions in treatment-resistant cancer cells.
Debruyne DN; Dries R; Sengupta S; Seruggia D; Gao Y; Sharma B; Huang H; Moreau L; McLane M; Day DS; Marco E; Chen T; Gray NS; Wong KK; Orkin SH; Yuan GC; Young RA; George RE
Nature; 2019 Aug; 572(7771):676-680. PubMed ID: 31391581
[TBL] [Abstract][Full Text] [Related]
32. CTCF and BORIS regulate Rb2/p130 gene transcription: a novel mechanism and a new paradigm for understanding the biology of lung cancer.
Fiorentino FP; Macaluso M; Miranda F; Montanari M; Russo A; Bagella L; Giordano A
Mol Cancer Res; 2011 Feb; 9(2):225-33. PubMed ID: 21325284
[TBL] [Abstract][Full Text] [Related]
33. MAGEA1 inhibits the expression of BORIS via increased promoter methylation.
Zhao J; Wang Y; Liang Q; Xu Y; Sang J
J Cell Sci; 2019 Jan; 132(1):. PubMed ID: 30498011
[TBL] [Abstract][Full Text] [Related]
34. BORIS/CTCFL is an RNA-binding protein that associates with polysomes.
Ogunkolade BW; Jones TA; Aarum J; Szary J; Owen N; Ottaviani D; Mumin MA; Patel S; Pieri CA; Silver AR; Sheer D
BMC Cell Biol; 2013 Nov; 14():52. PubMed ID: 24279897
[TBL] [Abstract][Full Text] [Related]
35. The cancer-associated CTCFL/BORIS protein targets multiple classes of genomic repeats, with a distinct binding and functional preference for humanoid-specific SVA transposable elements.
Pugacheva EM; Teplyakov E; Wu Q; Li J; Chen C; Meng C; Liu J; Robinson S; Loukinov D; Boukaba A; Hutchins AP; Lobanenkov V; Strunnikov A
Epigenetics Chromatin; 2016; 9(1):35. PubMed ID: 27588042
[TBL] [Abstract][Full Text] [Related]
36. Novel CTCF binding at a site in exon1A of BCL6 is associated with active histone marks and a transcriptionally active locus.
Batlle-López A; Cortiguera MG; Rosa-Garrido M; Blanco R; del Cerro E; Torrano V; Wagner SD; Delgado MD
Oncogene; 2015 Jan; 34(2):246-56. PubMed ID: 24362533
[TBL] [Abstract][Full Text] [Related]
37. Antitumor efficacy of DNA vaccination to the epigenetically acting tumor promoting transcription factor BORIS and CD80 molecular adjuvant.
Loukinov D; Ghochikyan A; Mkrtichyan M; Ichim TE; Lobanenkov VV; Cribbs DH; Agadjanyan MG
J Cell Biochem; 2006 Aug; 98(5):1037-43. PubMed ID: 16741971
[TBL] [Abstract][Full Text] [Related]
38. Does CTCF mediate between nuclear organization and gene expression?
Ohlsson R; Lobanenkov V; Klenova E
Bioessays; 2010 Jan; 32(1):37-50. PubMed ID: 20020479
[TBL] [Abstract][Full Text] [Related]
39. Dose-dependent activation of putative oncogene SBSN by BORIS.
Gaykalova D; Vatapalli R; Glazer CA; Bhan S; Shao C; Sidransky D; Ha PK; Califano JA
PLoS One; 2012; 7(7):e40389. PubMed ID: 22792300
[TBL] [Abstract][Full Text] [Related]
40. CCCTC-binding factor (CTCF) and cohesin influence the genomic architecture of the Igh locus and antisense transcription in pro-B cells.
Degner SC; Verma-Gaur J; Wong TP; Bossen C; Iverson GM; Torkamani A; Vettermann C; Lin YC; Ju Z; Schulz D; Murre CS; Birshtein BK; Schork NJ; Schlissel MS; Riblet R; Murre C; Feeney AJ
Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9566-71. PubMed ID: 21606361
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]